From the nervous system: drowsiness, dizziness, insomnia phenomena mental indifference, belated reaction to external stimuli. The use of triftazine is often accompanied by extrapyramidal racestriplets (dyskinesia, akinetorigidity phenomena, akathisia, hyperkinesia, tremor, autonomic disorders), in single cases convulsions. As proof-readers apply antiparkinsonian means - tropacin, trihexyphenidyl (cyclodol), etc. Dyskinesia (paroxysmally arising cramps in the muscles of the neck, tongue, mouth cavity, oculogic crises) are stopped by caffeine-sodium benzoate (2 ml of 20% solution subcutaneously) and atropine (1 ml 0.1% solution subcutaneously).
With prolonged reception, it is possible to develop late dyskinesia, less often - malignant neuroleptic syndrome.
From the sense organs: paresis of accommodation, with prolonged use - retinopathy, clouding of the lens and cornea.
On the part of the genitourinary system: urinary retention, decreased potency, frigidity, decreased libido, ejaculatory disorders, priapism, oliguria.
On the part of the endocrine system: hypo- or hyperglycemia, glucosuria, amenorrhea, hyperprolactinaemia, dysmenorrhea, galactorrhea, swelling or pain in the mammary glands, gynecomastia, weight gain.
On the part of the digestive system: dry mouth, decreased appetite, constipation, bulimia, nausea, vomiting, diarrhea, gastralgia, cholestatic jaundice.
From the sense organs: visual impairment - paresis of accommodation (at the beginning of treatment), retinopathy, clouding of the lens and cornea.
Laboratory indicators: thrombocytopenia, lympho- and leukopenia, rise blood coagulability, anemia, agranulocytosis (usually at 4-10 weeks of treatment), pancytopenia, eosinophilia - less frequently than in other phenothiazines, false positive pregnancy tests.
From the cardiovascular system: tachycardia, lowering blood pressure (including orthostatic hypotension), especially in elderly patients and people with alcoholism, heart rhythm disturbances, lengthening of the interval QT, decrease or inversion of the tooth T.
Allergic reactions: skin rash, hives, angioedema (less often than other phenothiazines).
Other: pigmentation of skin and conjunctiva, discoloration of sclera and cornea, a decrease in the tolerance of high temperatures (up to the development of heat stroke), melanosis
Local reactions: with intramuscular injection, infiltrates may occur, when liquid forms enter the skin-contact dermatitis.